PRVA
Privia Health Group, Inc. NASDAQ Listed Apr 28, 2021$23.94
Mkt Cap $3.0B
52w Low $18.77
66.8% of range
52w High $26.51
50d MA $22.81
200d MA $23.01
P/E (TTM)
130.8x
EV/EBITDA
55.0x
P/B
3.8x
Debt/Equity
0.0x
ROE
3.1%
P/FCF
17.9x
RSI (14)
—
ATR (14)
—
Beta
0.87
50d MA
$22.81
200d MA
$23.01
Avg Volume
844.7K
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
950 North Glebe Road · Arlington, VA 22203 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 23.99 | -4.3% | +0.0% | — | — | — | — | — |
| Feb 26, 2026 | AMC | 0.04 | 0.07 | +75.0% | 24.91 | +0.0% | -4.7% | +1.2% | -1.1% | +2.2% | -1.9% | — |
| Nov 6, 2025 | AMC | 0.06 | 0.05 | -16.7% | 23.98 | -0.5% | -2.3% | -0.1% | +3.9% | -0.4% | -1.9% | — |
| Aug 7, 2025 | AMC | 0.05 | 0.02 | -60.0% | 19.51 | +1.7% | +5.5% | -1.3% | +2.0% | +1.5% | -1.5% | — |
| May 8, 2025 | AMC | 0.06 | 0.03 | -50.0% | 25.07 | -0.2% | -0.2% | +0.2% | -3.0% | +0.0% | +2.5% | — |
| Feb 27, 2025 | AMC | 0.05 | 0.03 | -40.0% | 25.46 | +1.4% | -1.9% | -0.0% | +2.2% | +0.7% | -1.7% | — |
| Nov 7, 2024 | AMC | 0.05 | 0.03 | -40.0% | 22.53 | +0.7% | -5.5% | +7.0% | -1.0% | -3.3% | -0.7% | — |
| Aug 8, 2024 | AMC | 0.05 | 0.03 | -40.0% | 19.35 | +0.0% | -1.4% | +1.2% | +3.9% | -3.8% | +1.3% | — |
| May 9, 2024 | AMC | 0.05 | 0.02 | -60.0% | 18.03 | +1.4% | -0.3% | +0.1% | +0.3% | -3.8% | -2.1% | — |
| Feb 27, 2024 | AMC | 0.04 | 0.02 | -52.7% | 21.95 | -3.6% | -0.3% | +2.0% | +0.0% | -2.0% | -3.7% | — |
| Nov 3, 2023 | AMC | 0.05 | 0.05 | +0.0% | 23.52 | +0.7% | -4.0% | +2.1% | -2.7% | -2.5% | -0.4% | — |
| Aug 3, 2023 | AMC | 0.06 | 0.06 | +0.0% | 26.46 | +0.0% | +3.3% | -2.4% | -0.3% | +0.1% | +1.9% | — |
| May 4, 2023 | AMC | 0.02 | 0.06 | +228.5% | 27.43 | +0.9% | +6.1% | +2.9% | -2.9% | -4.5% | -2.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $22.38 | $22.87 | +2.2% | +1.5% | +0.0% | -1.5% | +2.9% | +0.5% |
| Mar 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $21.03 | $21.28 | +1.2% | -2.3% | -1.8% | -0.8% | +0.0% | +2.7% |
| Mar 3 | Citigroup | Maintains | Buy → Buy | — | $24.04 | $23.63 | -1.7% | -1.1% | +2.2% | -1.9% | -2.4% | +0.1% |
| Mar 2 | Truist | Maintains | Buy → Buy | — | $23.75 | $24.00 | +1.1% | +1.2% | -1.1% | +2.2% | -1.9% | -2.4% |
| Feb 27 | Canaccord Genuity | Maintains | Buy → Buy | — | $24.91 | $24.91 | +0.0% | -4.7% | +1.2% | -1.1% | +2.2% | -1.9% |
| Dec 4 | Stephens & Co. | Maintains | Overweight → Overweight | — | $24.30 | $24.30 | +0.0% | -1.2% | -0.7% | -0.9% | +0.7% | +1.6% |
| Nov 13 | JP Morgan | Maintains | Overweight → Overweight | — | $24.22 | $24.44 | +0.9% | -1.9% | -1.3% | -1.0% | -0.4% | -2.6% |
| Nov 12 | Canaccord Genuity | Maintains | Buy → Buy | — | $24.32 | $24.32 | +0.0% | -0.4% | -1.9% | -1.3% | -1.0% | -0.4% |
| Nov 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.43 | $23.56 | +0.6% | -0.1% | +3.9% | -0.4% | -1.9% | -1.3% |
| Nov 10 | Truist | Maintains | Buy → Buy | — | $23.43 | $23.56 | +0.6% | -0.1% | +3.9% | -0.4% | -1.9% | -1.3% |
| Nov 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $23.98 | $23.87 | -0.5% | -2.3% | -0.1% | +3.9% | -0.4% | -1.9% |
| Nov 7 | Citizens | Maintains | Market Outperform → Market Outperform | — | $23.98 | $23.87 | -0.5% | -2.3% | -0.1% | +3.9% | -0.4% | -1.9% |
| Oct 9 | Barclays | Maintains | Equal Weight → Equal Weight | — | $24.53 | $24.53 | +0.0% | -1.3% | -0.5% | +0.2% | +2.8% | +1.7% |
| Sep 24 | Stephens & Co. | Maintains | Overweight → Overweight | — | $23.48 | $23.54 | +0.3% | -0.6% | +0.1% | +2.6% | +1.9% | +2.0% |
| Sep 4 | Stephens & Co. | Maintains | Overweight → Overweight | — | $23.17 | $23.17 | +0.0% | -0.2% | +0.7% | +1.3% | -0.7% | -3.2% |
| Aug 29 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $21.81 | $22.99 | +5.4% | +5.6% | +0.7% | -0.1% | -0.2% | +0.7% |
| Aug 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $20.58 | $20.37 | -1.0% | -1.3% | +2.0% | +1.5% | -1.5% | +2.7% |
| Jul 9 | Evercore ISI | Maintains | Outperform → Outperform | — | $21.52 | $21.65 | +0.6% | -1.5% | -0.5% | -3.0% | +2.1% | -1.2% |
| May 28 | JP Morgan | Maintains | Overweight → Overweight | — | $23.32 | $23.37 | +0.2% | -1.1% | -2.3% | +0.9% | +0.3% | +0.6% |
| May 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $22.86 | $23.15 | +1.3% | +2.0% | -1.1% | -2.3% | +0.9% | +0.3% |
| Apr 28 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $23.17 | $23.21 | +0.2% | +0.1% | +0.9% | +0.3% | -2.5% | +1.8% |
| Apr 15 | Baird | Maintains | Outperform → Outperform | — | $24.05 | $24.07 | +0.1% | +0.6% | -1.3% | -0.8% | -4.1% | +0.7% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $23.05 | $22.65 | -1.7% | +2.6% | +1.9% | -0.2% | +0.6% | -1.3% |
| Apr 10 | Truist | Maintains | Buy → Buy | — | $23.05 | $22.65 | -1.7% | +2.6% | +1.9% | -0.2% | +0.6% | -1.3% |
| Apr 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.05 | $22.65 | -1.7% | +2.6% | +1.9% | -0.2% | +0.6% | -1.3% |
| Mar 21 | Needham | Maintains | Buy → Buy | — | $23.29 | $23.19 | -0.4% | +0.2% | +2.5% | -4.9% | +0.6% | +0.2% |
| Feb 28 | Needham | Maintains | Buy → Buy | — | $25.46 | $25.81 | +1.4% | -1.9% | -0.0% | +2.2% | +0.7% | -1.7% |
| Feb 28 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $25.46 | $25.81 | +1.4% | -1.9% | -0.0% | +2.2% | +0.7% | -1.7% |
| Feb 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $25.46 | $25.81 | +1.4% | -1.9% | -0.0% | +2.2% | +0.7% | -1.7% |
| Feb 28 | Piper Sandler | Maintains | Overweight → Overweight | — | $25.46 | $25.81 | +1.4% | -1.9% | -0.0% | +2.2% | +0.7% | -1.7% |
| Feb 14 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $24.87 | $25.00 | +0.5% | +1.5% | -0.8% | +1.8% | -3.4% | -0.5% |
| Jan 15 | Needham | Maintains | Buy → Buy | — | $21.00 | $21.39 | +1.9% | +2.7% | +1.3% | +1.8% | +2.2% | -0.2% |
| Jan 7 | Stephens & Co. | Maintains | Overweight → Overweight | — | $20.25 | $20.16 | -0.4% | +0.2% | +3.1% | -2.0% | +1.1% | +1.3% |
| Jan 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $19.55 | $19.70 | +0.8% | +0.5% | +1.6% | +1.5% | +0.2% | +3.1% |
| Nov 29 | JP Morgan | Maintains | Overweight → Overweight | — | $21.66 | $21.67 | +0.0% | -0.8% | +3.9% | -2.9% | +1.6% | -3.5% |
| Nov 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $22.53 | $22.68 | +0.7% | -5.5% | +7.0% | -1.0% | -3.3% | -0.7% |
| Nov 8 | Truist | Maintains | Buy → Buy | — | $22.53 | $22.68 | +0.7% | -5.5% | +7.0% | -1.0% | -3.3% | -0.7% |
| Aug 26 | Baird | Maintains | Outperform → Outperform | — | $20.86 | $21.06 | +1.0% | +2.1% | -2.5% | -1.5% | -1.3% | -0.2% |
| Aug 14 | RBC Capital | Maintains | Outperform → Outperform | — | $20.05 | $20.08 | +0.1% | -3.8% | +1.3% | +1.9% | +1.3% | -1.7% |
| Jul 9 | Evercore ISI | Maintains | Outperform → Outperform | — | $17.06 | $17.00 | -0.4% | +0.1% | +0.2% | +4.7% | +0.0% | +0.2% |
| May 20 | Barclays | Maintains | Equal Weight → Equal Weight | — | $16.90 | $16.81 | -0.5% | -4.8% | +0.4% | +1.8% | -2.0% | +7.4% |
| May 15 | Truist | Maintains | Buy → Buy | — | $18.05 | $18.36 | +1.7% | -3.8% | -2.1% | -0.6% | -4.8% | +0.4% |
| May 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $18.03 | $18.28 | +1.4% | -0.3% | +0.1% | +0.3% | -3.8% | -2.1% |
| May 1 | Stifel | Maintains | Buy → Buy | — | $18.40 | $18.17 | -1.2% | -2.0% | +2.1% | +1.8% | +1.8% | +0.9% |
| Mar 19 | Canaccord Genuity | Maintains | Buy → Buy | — | $20.14 | $20.09 | -0.2% | +3.7% | +0.1% | -4.5% | -1.8% | -2.7% |
| Mar 6 | JP Morgan | Maintains | Overweight → Overweight | — | $21.08 | $21.02 | -0.3% | +2.0% | +3.9% | +2.6% | -1.9% | -3.8% |
| Mar 1 | UBS | Maintains | Buy → Buy | — | $22.32 | $22.30 | -0.1% | +0.0% | -2.0% | -3.7% | +2.0% | +3.9% |
| Mar 1 | TD Cowen | Maintains | Outperform → Outperform | — | $22.32 | $22.30 | -0.1% | +0.0% | -2.0% | -3.7% | +2.0% | +3.9% |
| Feb 29 | Truist | Maintains | Buy → Buy | — | $21.88 | $22.24 | +1.6% | +2.0% | +0.0% | -2.0% | -3.7% | +2.0% |
| Feb 28 | Evercore ISI | Maintains | Outperform → Outperform | — | $21.95 | $21.16 | -3.6% | -0.3% | +2.0% | +0.0% | -2.0% | -3.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Mountcastle DavidOff | EVP & Chief Financial Officer | Sell | 1,206 | $25.00 | $30K | 214,847 | -1.24% | — |
| May 4, 2026 | Morris Matthew ShawnDir | — | Sell | 1,017 | $24.96 | $25K | 68,188 | -1.24% | — |
| May 1, 2026 | Mountcastle DavidOff | EVP & Chief Financial Officer | Sell | 7,179 | $25.03 | $180K | 214,847 | -1.24% | — |
| May 1, 2026 | Morris Matthew ShawnDir | — | Sell | 17,096 | $24.99 | $427K | 68,188 | -1.24% | — |
8-K · 2.02
!! High
Privia Health Group, Inc. -- 8-K 2.02: Earnings Results
Privia Health Group reported quarterly earnings results with detailed financial performance metrics, enabling investors to evaluate the healthcare services company's operational efficiency and revenue trends.
May 7
8-K
Privia Health Group, Inc. -- 8-K Filing
Privia Health Group exceeded its full-year 2025 guidance across operating and financial metrics, suggesting strong execution and potentially supporting investor confidence in the company's growth trajectory.
Feb 26
Data updated apr 26, 2026 8:55pm
· Source: massive.com